Pulse Biosciences, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $18.7M | $39.5M | $12.7M |
| Jun 2022 | $17.2M | $40.6M | $14.8M |
| Sep 2022 | $81.4M | $87.6M | $69.2M |
| Dec 2022 | $80.1M | $77.9M | $61.1M |
| Mar 2023 | $80.9M | $70.2M | $54.1M |
| Jun 2023 | $14.3M | $74.8M | $58.7M |
| Sep 2023 | $13.8M | $65.9M | $50.4M |
| Dec 2023 | $14.8M | $59.2M | $44.4M |
| Mar 2024 | $12.9M | $49.2M | $34.9M |
| Jun 2024 | $13.5M | $40.4M | $26.2M |
| Sep 2024 | $13.9M | $93.0M | $79.0M |
| Dec 2024 | $17.6M | $132.5M | $118.0M |
| Mar 2025 | $14.9M | $133.4M | $119.3M |
| Jun 2025 | $15.8M | $120.3M | $106.3M |
| Sep 2025 | $16.1M | $108.8M | $95.2M |
| Dec 2025 | $13.9M | $94.5M | $80.7M |
| Mar 2026 | $15.3M | $81.6M | $68.3M |
| Jun 2026 | $16.1M | $115.6M | $101.6M |